Antiplaque activity

Antiplaque activity refers to a pharmacological or clinical endpoint rather than a single molecular target like a receptor or enzyme. It describes the capacity of a substance to inhibit the formation, accumulation, or pathogenicity of dental plaque, which is a complex multispecies biofilm consisting of bacteria such as Streptococcus mutans and Actinomyces species embedded in an extracellular matrix (PubMed, 2021). Because dental plaque is a community-level biological structure, antiplaque agents act on a variety of microbial targets simultaneously or modify the tooth surface environment to prevent bacterial colonization. Common therapeutic agents, including chlorhexidine and various essential oils, exert their effects by lysing bacterial cells or disrupting the chemical bonds that allow the biofilm to adhere to enamel (Journal of Clinical Periodontology, 2020). Consequently, in drug discovery databases like ChEMBL, 'Antiplaque activity' is typically categorized as an assay measurement or a therapeutic property rather than a specific protein target.

Other names

Plaque inhibitionDental biofilm reductionAntiplaque effect

Inhibition of plaque occurs through the disruption of bacterial cell membranes, interference with microbial metabolism, and the prevention of bacterial attachment to the dental pellicle (National Center for Biotechnology Information, 2023).